Works matching IS 11720360 AND DT 2025 AND VI 41 AND IP 2

Results: 8

Efficiently Reducing Medical Costs through Drug Vial Optimization and Multidose Vials for the Utilization of Cancer Drug Compounding Robots: Efficiently Reducing Medical Costs through Cancer Drug Compounding Robots: E. Usami et al.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 75, doi. 10.1007/s40267-025-01140-w

By:

Usami, Eiseki;
Moriya, Akihiro;
Jimichi, Taiga;
Asano, Hiroki;
Miyazaki, Masayuki;
Hirabatake, Masaki;
Muroi, Nobuyuki;
Tonogai, Yuki;
Hibi, Yoko;
Kimura, Michio

Publication type:

Article

Manage acne in pregnancy with limited choices and extra considerations.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 59, doi. 10.1007/s40267-024-01138-w

By:

Kang, Connie;
Hoy, Sheridan M.

Publication type:

Article

Correction: Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use.

Published in:

2025

By:

Syed, Yahiya Y.

Publication type:

Correction Notice

Initiate treatment with inflammatory modulators early in adult-onset Still's disease: Initiate treatment with inflammatory modulators: C. Fenton, S. Fung.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 55, doi. 10.1007/s40267-024-01136-y

By:

Fenton, Caroline;
Fung, Simon

Publication type:

Article

The role of digital health in the management of warfarin therapy.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 63, doi. 10.1007/s40267-024-01134-0

By:

Sangam, Shreya;
Gudi, Sai Krishna

Publication type:

Article

Correction: Ritlecitinib in severe alopecia areata: a profile of its use.

Published in:

2025

By:

Shirley, Matt

Publication type:

Correction Notice

Adis summary of research: Lebrikizumab improves quality of life and patient-reported symptoms of anxiety and depression in patients with moderate-to-severe atopic dermatitis: Lebrikizumab improves quality of life: H. A. Blair.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 45, doi. 10.1007/s40267-024-01132-2

By:

Blair, Hannah A.

Publication type:

Article

Cantharidin 0.7% topical solution (YCANTH<sup>®</sup>) in molluscum contagiosum: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 47, doi. 10.1007/s40267-024-01131-3

By:

Zhuang-Yan, Amy;
Blair, Hannah A.

Publication type:

Article